[Pfizer Inc.](https://www.pfizer.com)

May 21, 2026 (Submission deadline, full application — 23:59 EST)

Up to $100,000 per project; project duration up to 12 months.

Supports independent medical education projects to advance evidence-based understanding and clinical application of generic JAK inhibitors in rheumatologic disease management.

Only organizations (not individuals or unaffiliated practice groups) are eligible; U.S.-based projects only.

--- ## Description This grant opportunity from Pfizer Inc. is designed to fund independent medical education projects that enhance healthcare professionals’ understanding of the clinical impact, appropriate use, and evolving role of a generic JAK inhibitor in the management of rheumatologic diseases. Proposals should focus on translating data-driven insights and emerging real-world evidence into practical clinical decision-making. Educational initiatives may include case-based demonstrations, systematic data analysis, and interactive formats such as roundtable discussions, seminars, symposia, or webinars. Projects must define measurable educational outcomes, demonstrate knowledge gains, and encourage dissemination of insights through publications or other means to advance discourse in rheumatology. --- ## Due Dates - May 21, 2026: Submission deadline (full application) — 23:59 Eastern Standard Time Anticipated grant award notification: July 7, 2026 Anticipated project start date: October 2026 Anticipated project end date: October 2027 --- ## Funding Amount - Individual projects may request up to $100,000 USD. - Maximum project duration is 12 months. - The total estimated available budget for this RFP is $100,000 USD. - Award amounts include direct costs and institutional overhead (capped at 28% per Pfizer policy). --- ## Eligibility - **Geographic Scope:** United States - **Eligible Applicants:** - Organizations with a mission related to healthcare professional education and/or healthcare improvement, including: - Healthcare institutions (e.g., academic medical centers, hospitals) - Professional organizations/medical societies - Medical education companies - Other healthcare-related entities - The project/program lead must be an employee or contractor of the requesting organization. - Only organizations are eligible to receive grants; individuals and unaffiliated medical practice groups are not eligible. - The requesting organization must be legally able to receive funding directly from Pfizer Inc. - For projects offering continuing education credit, the organization must be accredited. - Multi-institutional projects must clearly define roles for all partners. --- ## Application Process - Applications must be submitted via the [Pfizer CyberGrants portal](http://www.cybergrants.com/pfizer/knowledge). - Sign in or create an account. - Start a new "Knowledge Gap Application." - For "Competitive Grant?" select "Yes." - Select "Rheumatology - General/Non-specific/Other – KG" as the Primary Area of Interest. - Select "2026 I&I US JAKi Rheum IME" as the Competitive Grant Program Name. - Upload a proposal (maximum 15 pages, single-spaced, Calibri 12-point font, 1-inch margins) addressing required sections (see RFP for details). - Required proposal sections include: - Goals and objectives - Assessment of need (with supporting data) - Target audience description - Project design and methods - Innovation and originality - Evaluation and outcomes - Dissemination plan - Project timeline - Organization detail and roles - Budget narrative (with up to 28% overhead allowed) - Only applications submitted before the deadline will be reviewed. --- ## Additional Information - Priority will be given to face-to-face roundtable discussions, but other educational formats (seminars, symposia, webinars) are eligible. - Projects should not include clinical research or evaluation of therapeutic/diagnostic efficacy. - Clear educational metrics and dissemination plans are required. - Grant agreements must be executed with Pfizer; modifications are limited. --- ## External Links - [Pfizer Competitive Grants Program Overview](https://www.pfizer.com/about/programs-policies/grants/competitive-grants) - [Full RFP Document (PDF)](https://cdn.pfizer.com/pfizercom/2026-03/2026-I_I-US-JAKiRheum-IME.pdf?VersionId=vqGlrLzKukKOtNRME1T9.Q6t4pr9LLDl) - [Pfizer CyberGrants Application Portal](http://www.cybergrants.com/pfizer/knowledge) --- ## Contact Information | Purpose | Contact/Link | |--------------------------|------------------------------------------------------------------------------| | General Grant Questions | Talita Honorato-Rzeszewicz, Grant Officer
[talita.honorato-rzeszewicz@pfizer.com](mailto:talita.honorato-rzeszewicz@pfizer.com) | | Technical Support | Use the "Technical Questions" link at the bottom of the [CyberGrants portal](http://www.cybergrants.com/pfizer/knowledge) | | Pfizer General Contact | 1-800-879-3477
[Pfizer Contact Page](https://www.pfizer.com/contact) |

Pfizer Independent Medical Education Grant Request for Proposals: Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases

Sign in to see full grant listing